Aveo raises $15 million, hires CMO

Cancer company Aveo ( Cambridge, Mass.) raised $15 million in debt from Hercules Technology Growth Capital (HTGC). Aveo's lead compound, AV-412 ( MP-412), is expected to begin clinical testing in solid tumors by mid-year. The company has ex-Asian rights to the multiple kinase inhibitor from Mitsubishi Pharma (Osaka, Japan). ...